Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MLNR | O43193 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | GPR6 | P46095 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10077967 | 0.81 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3HRH3SMN1; SMN2 | |
| SCHEMBL10260953 | 0.80 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3HRH3SMN1; SMN2 | |
| SCHEMBL17339944 | 0.80 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3HRH3SMN1; SMN2 | |
| SCHEMBL10267101 | 0.79 | HTR1F (0.48) | HRH3 | |
| SCHEMBL10267816 | 0.79 | HTR1F (0.48) | HRH3 | |
| SCHEMBL10259186 | 0.79 | HTR1F (0.48) | HRH3 | |
| SCHEMBL13675029 | 0.79 | HTR1F (0.48) | HRH3 | |
| SCHEMBL4491580 | 0.79 | HTR1F (0.48) | HRH3 | |
| SCHEMBL28099496 | 0.76 | POLB (0.41) | KMT2AUSP2 | |
| SCHEMBL157429 | 0.75 | SLC6A3 (0.67) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797082-B1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMA CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |